MDWD 241220 30.00P (MDWD241220P30000) Stock Options, News & Quotes

US OptionsDetailed Quotes

MDWD241220P30000

Watchlist

0.00
0.000.00%

15min DelayClose Nov 26 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

TD Cowen Maintains MediWound(MDWD.US) With Buy Rating, Maintains Target Price $25
Moomoo News14:32 ET · Ratings
MediWound Ltd. (MDWD) Q3 2024 Earnings Call Transcript
Earnings Call Transcripts13:46 ET
Mediwound's Promising Outlook: Expansion and Trials Support Buy Rating
TipRanks13:35 ET · Ratings
MediWound Advances With FDA Approval and New Funding
TipRanksNov 26 07:29 ET
MediWound Ltd. Advances Development With EscharEx IND Submission Planned for Year-End and NexoBrid FDA Pediatric Approval
Quiver QuantitativeNov 26 07:12 ET
MediWound Q3 2024 GAAP EPS $(0.98) Misses $(0.45) Estimate, Sales $4.36M Miss $6.01M Estimate
BenzingaNov 26 07:08 ET

Comments

Trytosaveabit

Aug 15 15:19

News

$MediWound (MDWD.US)$ Reuters
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns

Trytosaveabit

Jul 15 06:04

Update

$MediWound (MDWD.US)$ Mediwound Ltd - to Sell 1,453,488 Ordinary Shares at 17.20 PS

careful Llama_7306

Jul 5 08:47

$MediWound (MDWD.US)$ any thoughts??

Trytosaveabit

Jul 5 07:27

Hmm?

$MediWound (MDWD.US)$ Watching / Looking for confirmation of rumor that $Solventum (SOLV.US)$ is offering a $34 PS takeover bid?

Trytosaveabit

Jan 9 06:05

Update

$MediWound (MDWD.US)$ MediWound Says FDA Accepted For Review The Supplement To The NexoBrid BLA To Include Pediatric Patients With Severe Thermal Burns